Healthcare insurance company Molina Healthcare (NYSE: MOH) will be reporting earnings this Wednesday afternoon. Here’s what investors should know.
Molina Healthcare beat analysts’ revenue expectations by 2.6% last quarter, reporting revenues of $11.15 billion, up 12.2% year on year. It was a satisfactory quarter for the company, with a decent beat of analysts’ EPS estimates but customer base in line with analysts’ estimates. It added 217,000 customers to reach a total of 5.75 million.
Is Molina Healthcare a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Molina Healthcare’s revenue to grow 10.8% year on year to $10.95 billion, slowing from the 18.7% increase it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Molina Healthcare has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 3.2% on average.
Looking at Molina Healthcare’s peers in the healthcare providers & services segment, only Elevance Health has reported results so far. It beat analysts’ revenue estimates by 3%, delivering year-on-year sales growth of 13.4%. The stock was down 19.7% on the results.
Read our full analysis of Elevance Health’s earnings results here.Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.1% on average over the last month. Molina Healthcare is down 39.5% during the same time.
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
